EP2288359
GENETICALLY MODIFIED HUMAN UMBILICAL CORD PERIVASCULAR CELLS FOR PROPHYLAXIS AGAINST OR TREATMENT OF BIOLOGICAL OR CHEMICAL AGENTS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
20.4.2009EP published:
2.10.2019EP application number:
09734792.6
EPO information:
European Patent Register
Max expiry date:
19.4.2029
Title:
GENETICALLY MODIFIED HUMAN UMBILICAL CORD PERIVASCULAR CELLS FOR PROPHYLAXIS AGAINST OR TREATMENT OF BIOLOGICAL OR CHEMICAL AGENTS
Timeline
Today
20.4.2009EP application
2.10.2019EP Publication
Owner
Name:
Tissue Regeneration Therapeutics Inc.Address:
790 Bay Street, Suite 512 P.O. Box 55, Toronto, Ontario M5G 1N8, CA
Inventor
Name:
ENNIS, Jane ElizabethAddress:
OakvilleOntario L6J 6E5, CA
Name:
TURNER, Jeffrey DonaldAddress:
Chute-a-BlondeauOntario K0B 1B0, CA
Name:
DAVIES, John EdwardAddress:
TorontoOntario M6R 1J4, CA
Priority
Number:
46630 PDate:
21.4.2008Country:
US
Classification
Categories:
A61K 35/44, A61K 39/00, A61P 31/00, A61P 33/00, A61P 37/04, A61P 39/00, A61K 48/00, C07K 14/08, C07K 14/555, C07K 16/10, C12N 15/67, C12N 15/85, C12N 5/10